CA
CPBIO Holding Company Limited
CAIHF · OTC
$1.07 +0.00% (+$0.00)
Market Cap $829.2M
P/E Ratio 33.94x
Div. Yield -
ROE 8.74%
Bulios Fair Price
$0.57
46.6% downside
Current Price
$1.07
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CAIHF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
38 /100
Fair P/B 2.82x
P/S 1.96x
P/E 33.94x
Growth
91 /100
Growing Book val. growth 6.31%
Rev. growth 49.81%
FCF growth N/A
Profitability
23 /100
Weak FCF margin 0.00%
Op. margin 7.07%
Gross margin 16.60%
Quality
42 /100
Average Asset turnover 0.84x
ROA 4.84%
ROIC 5.92%
Debt
91 /100
Low Net debt/EBITDA 1.23x
Int. coverage 25.44x
Debt/Equity 0.26x
Stability
11 /100
Unstable Profitable years 3
EPS volatility 103.49%
Beta 3.98x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CAIHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chawalit Na Muangtoun
Employees
900
Headquarters
Hong Kong